Apronal
Template:Short description Template:Short description <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =
| _has_physiological_data= | _has_gene_therapy=
| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=91622O=C(NC(=O)N)C(C(C)C)C\C=CRacemic mixture1S/C9H16N2O2/c1-4-5-7(6(2)3)8(12)11-9(10)13/h4,6-7H,1,5H2,2-3H3,(H3,10,11,12,13)KSUUMAWCGDNLFK-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data= OralN05 | _legal_data=
| _other_data=(±)-N-Carbamoyl-2-propan-2-ylpent-4-enamide
| _image_0_or_2 = Apronal.svgApronal 3D.png | _image_LR =
| _datapage = Apronal (data page) | _vaccine_target=_type_not_vaccine | _legal_all= | _ATC_prefix_supplemental=N05 | _has_EMA_link = | CAS_number=528-92-7 | PubChem=10715 | ChemSpiderID=10264 | ChEBI= | ChEMBL=509282 | DrugBank= | KEGG=D03975 | _hasInChI_or_Key=yes | UNII=V18J24E25E | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =
| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields= |Watchedfields=changed |verifiedrevid=443395760}}
Apronal (brand name Sedormid), or apronalide, also known as allylisopropylacetylurea or allylisopropylacetylcarbamide, is a hypnotic/sedative drug of the ureide (acylurea) group synthesized in 1926[1] by Hoffmann-La Roche. Though it is not a barbiturate, apronal is similar in structure to the barbiturates (being an open-chain carbamide instead of having a heterocyclic ring).[2] In accordance, it is similar in action to the barbiturates, although considerably milder in comparison (formerly used as a daytime sedative at doses of 1 to 2 grams every 3 to 4 hours).[2] Upon the finding that it caused patients to develop thrombocytopenic purpura, apronal was withdrawn from clinical use.[3]
Medicines with apronal are no longer used except in Japan.[3] Notably Australian Therapeutic Goods Administration issued a safety alert in May 2023 which prohibits the sale, supply and use of Japanese EVE-branded products in Australia[4] due to its dangerous side effects.
See also
References
<templatestyles src="Reflist/styles.css" />
- ↑ <templatestyles src="Citation/styles.css"/>Template:Citation/make link, "Verfahren zur Darstellung von Ureiden der Dialkylessigsaeuren", issued Script error: No such module "auto date formatter"., assigned to Hoffmann-La RocheScript error: No such module "Check for unknown parameters".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
Script error: No such module "Check for unknown parameters".
Script error: No such module "navbox". Template:GABAAergics